Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase 0 Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer

Summary

The purpose of this study is to evaluate stereotactic radiosurgery (CyberKnife) plus chemotherapy for the treatment of potentially resectable adenocarcinoma of the pancreas.

General Information

NCT#: NCT02707315
Study ID: 12-169
Trial Phase: Phase 0

Trial Sponsor: The Cooper Health System
Therapies Used in This Trial: Gemcitabine, CyberKnife® Stereotactic Radiosurgery

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search